Uncover key drivers, emerging technologies, and competitive movements shaping the molecular diagnostics for sexually transmitted diseases market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Molecular Diagnostics For Sexually Transmitted Diseases Market?

The market size for molecular diagnostics addressing sexually transmitted diseases has experienced substantial growth in recent years. This market is forecasted to expand from $3.31 billion in 2024 to $3.67 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this growth can be credited to the escalating prevalence of sexually transmitted infections, the increasing utilization of nucleic acid amplification tests, enhanced awareness fostered by government screening programs, backing from global health organizations, and swift adoption in diagnostic laboratories.

The molecular diagnostics for sexually transmitted diseases market size is poised for substantial growth over the next few years, with projections indicating it will reach $5.48 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.5%. This anticipated expansion during the forecast period can be attributed to an increased focus on early disease detection, a rising need for personalized diagnostics, the extension of sexually transmitted infection surveillance initiatives, the proliferation of public-private partnerships, and an escalating preference for non-invasive testing methodologies. Key developments expected in this period include technological advancements in molecular assay platforms, innovations in point-of-care diagnostic devices, the development of multiplex polymerase chain reaction (PCR)-based testing panels, dedicated research and development for portable and automated systems, and the incorporation of artificial intelligence in interpreting diagnostic results.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27351&type=smp

Which Industry Forces Are Driving The Molecular Diagnostics For Sexually Transmitted Diseases Market Forward?

The increasing incidence of sexually transmitted infections is anticipated to boost the expansion of the molecular diagnostics for sexually transmitted diseases market in the future. Sexually transmitted infections, or STIs, are infections resulting from bacteria, viruses, or parasites passed during sexual contact, impacting the reproductive and urinary systems. The rising occurrence of STIs largely stems from irregular use of protective measures. This insufficient protection contributes to the simpler spread of these infections among sexually active people. Molecular diagnostic tools for sexually transmitted infections (STIs) are vital in managing these conditions, as they allow for the prompt and precise identification of pathogens, even in individuals without symptoms, thereby supporting swift treatment, lowering disease transmission, and enhancing patient well-being. As an illustration, in January 2024, the National Association of County and City Health Officials (NACCHO), a US-based nonprofit organization, reported 3,755 cases of congenital syphilis, indicating a 31% increase between 2021 and 2022. Consequently, the escalating prevalence of sexually transmitted infections is fueling the expansion of the molecular diagnostics for sexually transmitted diseases market.

How Is The Molecular Diagnostics For Sexually Transmitted Diseases Market Organized By Different Segments?

The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented

1) By Product: Instruments And Services, Consumables, Software

2) By Technology: Laboratory Testing, Point-Of-Care Testing

3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications

Subsegment:

1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services

2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers

3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software

What Current And Upcoming Trends Are Shaping The Molecular Diagnostics For Sexually Transmitted Diseases Market?

Leading companies in the molecular diagnostics for sexually transmitted diseases market are dedicated to developing innovative solutions, such as swift point-of-care polymerase chain reaction (PCR) devices, to enhance diagnostic speed, accuracy, and accessibility. These rapid point-of-care polymerase chain reaction (PCR) devices are portable molecular diagnostic tools that integrate sample preparation, amplification, and detection into a singular, compact unit, facilitating timely and highly sensitive pathogen detection outside conventional laboratory environments. As an illustration, in March 2025, Visby Medical, a US-based diagnostic technology company, introduced the Visby Medical Women’s Sexual Health Test. This product is a single-use, handheld PCR device crafted to identify chlamydia, gonorrhea, and trichomoniasis from vaginal samples within 30 minutes. It operates without requiring external instrumentation or cold-chain logistics, includes an integrated amplification system, and delivers lab-quality results directly at the point of care to enable prompt clinical decisions. The test is approved for prescription home use, establishing it as the first U.S. Food and Drug Administration (FDA)-cleared molecular diagnostic test for multiple sexually transmitted infections (STIs) that can be utilized beyond clinical settings. This launch underscores a shift towards decentralized diagnostic solutions that improve accessibility, particularly for underserved or remote populations.

Who Are The Primary Market Leaders In The Molecular Diagnostics For Sexually Transmitted Diseases Market?

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, and Solone Life Sciences India (P) Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-for-sexually-transmitted-diseases-global-market-report

How Do Regional Dynamics Influence The Molecular Diagnostics For Sexually Transmitted Diseases Market Performance?

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27351&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics For Sexually Transmitted Diseases Market 2025, By The Business Research Company

Personal Loans Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-loans-global-market-report

Household Insecticides Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Household Lending Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/household-lending-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model